Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.

Journal of cancer research and clinical oncology - 1 Jul 2002

Lage Hermann, Dietel Manfred

Abstract excerpt

PURPOSE: Drug-resistant phenotypes of cancer cells may be caused by complex multimodal mechanisms of resistance. In order to gain further insighte into these mechanisms, a P-glycoprotein-mediated multidrug-resistant phenotype induced by daunorubicin-selection and an alternative drug resistance due to treatment with mitoxantrone were investigated in pancreatic carcinoma-derived cells. METHODS: For assessing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Biological Transport

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Survival

Share to Daunorubicin

Share to DNA Topoisomerases, Type II

Share to Drug Resistance, Neoplasm

Share to Mitoxantrone

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 12136248
DOI: 10.1007/s00432-002-0349-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.PMID 12136248Read ↗

Challenges of drug resistance in the management of pancreatic cancerSemantic proximity Read ↗

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.Semantic proximity Read ↗

Overcoming drug resistance in pancreatic cancer.Semantic proximity Read ↗

Review. Molecular background of chemoresistance in pancreatic cancer.Semantic proximity Read ↗

Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Semantic proximity Read ↗

Mechanisms regulating resistance to inhibitors of topoisomerase IISemantic proximity Read ↗

Drug ResistanceSemantic proximity Read ↗

Prediction of Broad Spectrum Resistance of Tumors towards Anticancer DrugsSemantic proximity Read ↗

Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.Semantic proximity Read ↗

Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes.Semantic proximity Read ↗

[Multiple drug resistance].Semantic proximity Read ↗

Chromosomal imbalances associated with drug resistance and thermoresistance in human pancreatic carcinoma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.